FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760171477> ?p ?o ?g. }

• W2760171477 abstract "Previous studies have explored the anti-diabetic effects of Cinnamomum cassia extract in vivo and in vitro. However, there are no studies at present exploring the effects of the indigenous species of Sri Lankan cinnamon (Cinnamomum zeylanicum) in patients with diabetes mellitus. The present study aims to evaluate the potential effects of Cinnamomum zeylanicum extract as a pharmaceutical agent in patients with type-2 diabetes mellitus. The study will be conducted as a randomized, double-blind, placebo-controlled clinical trial for a period of 4 months at the Medical Clinic, University Medical Unit, National Hospital of Sri Lanka. A total of 210 subjects with diabetes, in three equal groups, will be recruited for the study. The patients will be randomized in a 1:1:1 ratio according to the method of block randomization and the subjects will be randomly and equally assigned into two test groups (n = 70 each) and one placebo group (n = 70). The population will be stratified at randomization based on age, gender and disease severity. The treatment drug is a capsule containing Cinnamomum zeylanicum extract as the active ingredient and the placebo capsule will contain lactose monohydrate. Two doses of Cinnamomum zeylanicum extracts (250 mg and 500 mg of the cinnamon extract) will be used. The study drugs will be double blinded to both investigators and participants. The visits and the evaluations will be done as follows: screening (visit 0), 1 month (visit 1), 2 months (visit 2), 3 months (visit 3) and 4 months (visit 4). The following primary outcome measures will be evaluated: glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) and serum insulin. Secondary outcome measures include: Body Mass Index (BMI) and other anthropometric parameters, blood pressure, total cholesterol, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglycerides (TAG). Data will be analyzed using SPSS version 14. We describe the protocol for a clinical trial design evaluating the effects of Cinnamomum zeylanicum (Ceylon cinnamon) in patients with type-2 diabetes mellitus. The result of the present study, positive or negative, should provide a step change in the evidence guiding current and future policies regarding the use of cinnamon dietary supplementation in patients with diabetes. Sri Lanka Clinical Trials Registry (SLCTR), identifier: SLCTR/2017/010 ( http://slctr.lk/trials/714 ). Registered on 5 April 2017; study protocol version 3.1 21 March 2017." @default.
• W2760171477 created "2017-10-06" @default.
• W2760171477 creator A5009830085 @default.
• W2760171477 creator A5034975301 @default.
• W2760171477 creator A5046131398 @default.
• W2760171477 creator A5051292791 @default.
• W2760171477 creator A5056723208 @default.
• W2760171477 creator A5071072347 @default.
• W2760171477 creator A5091399280 @default.
• W2760171477 date "2017-09-29" @default.
• W2760171477 modified "2023-10-18" @default.
• W2760171477 title "Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial" @default.
• W2760171477 cites W1493486107 @default.
• W2760171477 cites W1555322723 @default.
• W2760171477 cites W1969276623 @default.
• W2760171477 cites W1992972279 @default.
• W2760171477 cites W2001158976 @default.
• W2760171477 cites W2013332068 @default.
• W2760171477 cites W2020267609 @default.
• W2760171477 cites W2039961296 @default.
• W2760171477 cites W2045039436 @default.
• W2760171477 cites W2058527493 @default.
• W2760171477 cites W2075590923 @default.
• W2760171477 cites W2078460365 @default.
• W2760171477 cites W2080081478 @default.
• W2760171477 cites W2125420530 @default.
• W2760171477 cites W2125671730 @default.
• W2760171477 cites W2126986212 @default.
• W2760171477 cites W2127795692 @default.
• W2760171477 cites W2129941041 @default.
• W2760171477 cites W2131680108 @default.
• W2760171477 cites W2145135198 @default.
• W2760171477 cites W2145546397 @default.
• W2760171477 cites W2157427421 @default.
• W2760171477 cites W2166023752 @default.
• W2760171477 cites W2171129594 @default.
• W2760171477 cites W2225477683 @default.
• W2760171477 cites W2414971374 @default.
• W2760171477 cites W2781295823 @default.
• W2760171477 cites W4235462019 @default.
• W2760171477 cites W4239408478 @default.
• W2760171477 doi "https://doi.org/10.1186/s13063-017-2192-0" @default.
• W2760171477 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5622575" @default.
• W2760171477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28962661" @default.
• W2760171477 hasPublicationYear "2017" @default.
• W2760171477 type Work @default.
• W2760171477 sameAs 2760171477 @default.
• W2760171477 citedByCount "35" @default.
• W2760171477 countsByYear W27601714772018 @default.
• W2760171477 countsByYear W27601714772019 @default.
• W2760171477 countsByYear W27601714772020 @default.
• W2760171477 countsByYear W27601714772021 @default.
• W2760171477 countsByYear W27601714772022 @default.
• W2760171477 countsByYear W27601714772023 @default.
• W2760171477 crossrefType "journal-article" @default.
• W2760171477 hasAuthorship W2760171477A5009830085 @default.
• W2760171477 hasAuthorship W2760171477A5034975301 @default.
• W2760171477 hasAuthorship W2760171477A5046131398 @default.
• W2760171477 hasAuthorship W2760171477A5051292791 @default.
• W2760171477 hasAuthorship W2760171477A5056723208 @default.
• W2760171477 hasAuthorship W2760171477A5071072347 @default.
• W2760171477 hasAuthorship W2760171477A5091399280 @default.
• W2760171477 hasBestOaLocation W27601714771 @default.
• W2760171477 hasConcept C126322002 @default.
• W2760171477 hasConcept C134018914 @default.
• W2760171477 hasConcept C142724271 @default.
• W2760171477 hasConcept C168563851 @default.
• W2760171477 hasConcept C185592680 @default.
• W2760171477 hasConcept C204787440 @default.
• W2760171477 hasConcept C27081682 @default.
• W2760171477 hasConcept C2777278459 @default.
• W2760171477 hasConcept C2908647359 @default.
• W2760171477 hasConcept C2909396168 @default.
• W2760171477 hasConcept C2910652673 @default.
• W2760171477 hasConcept C43617362 @default.
• W2760171477 hasConcept C555293320 @default.
• W2760171477 hasConcept C556039675 @default.
• W2760171477 hasConcept C71924100 @default.
• W2760171477 hasConcept C99454951 @default.
• W2760171477 hasConceptScore W2760171477C126322002 @default.
• W2760171477 hasConceptScore W2760171477C134018914 @default.
• W2760171477 hasConceptScore W2760171477C142724271 @default.
• W2760171477 hasConceptScore W2760171477C168563851 @default.
• W2760171477 hasConceptScore W2760171477C185592680 @default.
• W2760171477 hasConceptScore W2760171477C204787440 @default.
• W2760171477 hasConceptScore W2760171477C27081682 @default.
• W2760171477 hasConceptScore W2760171477C2777278459 @default.
• W2760171477 hasConceptScore W2760171477C2908647359 @default.
• W2760171477 hasConceptScore W2760171477C2909396168 @default.
• W2760171477 hasConceptScore W2760171477C2910652673 @default.
• W2760171477 hasConceptScore W2760171477C43617362 @default.
• W2760171477 hasConceptScore W2760171477C555293320 @default.
• W2760171477 hasConceptScore W2760171477C556039675 @default.
• W2760171477 hasConceptScore W2760171477C71924100 @default.
• W2760171477 hasConceptScore W2760171477C99454951 @default.
• W2760171477 hasFunder F4320326055 @default.
• W2760171477 hasIssue "1" @default.
• W2760171477 hasLocation W27601714771 @default.
• W2760171477 hasLocation W27601714772 @default.
• W2760171477 hasLocation W27601714773 @default.

• next